Våbenø J - Search Results

1

Identification of a Salt Bridge That Is Functionally Important for Chemokine Receptor CXCR1 but not CXCR2.

Våbenø J, Oliva-Santiago M, Jørgensen AS, Karlshøj S, Rosenkilde MM. Våbenø J, et al. ACS Pharmacol Transl Sci. 2023 Jul 14;6(8):1120-1128. doi: 10.1021/acsptsci.3c00070. eCollection 2023 Aug 11. ACS Pharmacol Transl Sci. 2023. PMID: 37588755 Free PMC article.

2

Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations.

Våbenø J, Nielsen CU, Ingebrigtsen T, Lejon T, Steffansen B, Luthman K. Våbenø J, et al. J Med Chem. 2004 Sep 9;47(19):4755-65. doi: 10.1021/jm040780c. J Med Chem. 2004. PMID: 15341490

3

Rational design of conformationally constrained cyclopentapeptide antagonists for C-x-C chemokine receptor 4 (CXCR4).

Mungalpara J, Thiele S, Eriksen Ø, Eksteen J, Rosenkilde MM, Våbenø J. Mungalpara J, et al. Among authors: vabeno j. J Med Chem. 2012 Nov 26;55(22):10287-91. doi: 10.1021/jm300926y. Epub 2012 Oct 22. J Med Chem. 2012. PMID: 23043442

4

Structure-activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists.

Mungalpara J, Zachariassen ZG, Thiele S, Rosenkilde MM, Våbenø J. Mungalpara J, et al. Among authors: vabeno j. Org Biomol Chem. 2013 Dec 21;11(47):8202-8. doi: 10.1039/c3ob41941j. Epub 2013 Oct 23. Org Biomol Chem. 2013. PMID: 24150741

5

Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis.

Thiele S, Mungalpara J, Steen A, Rosenkilde MM, Våbenø J. Thiele S, et al. Among authors: vabeno j. Br J Pharmacol. 2014 Dec;171(23):5313-29. doi: 10.1111/bph.12842. Br J Pharmacol. 2014. PMID: 25039237 Free PMC article.

6

Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).

Zachariassen ZG, Thiele S, Berg EA, Rasmussen P, Fossen T, Rosenkilde MM, Våbenø J, Haug BE. Zachariassen ZG, et al. Among authors: vabeno j. Bioorg Med Chem. 2014 Sep 1;22(17):4759-69. doi: 10.1016/j.bmc.2014.07.004. Epub 2014 Jul 14. Bioorg Med Chem. 2014. PMID: 25082513

7

Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.

Våbenø J, Haug BE, Rosenkilde MM. Våbenø J, et al. Future Med Chem. 2015;7(10):1261-83. doi: 10.4155/fmc.15.64. Future Med Chem. 2015. PMID: 26144264 Review.

8

Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636).

Zachariassen ZG, Karlshøj S, Haug BE, Rosenkilde MM, Våbenø J. Zachariassen ZG, et al. Among authors: vabeno j. J Med Chem. 2015 Oct 22;58(20):8141-53. doi: 10.1021/acs.jmedchem.5b00987. Epub 2015 Oct 2. J Med Chem. 2015. PMID: 26397724

9

Influence of chain length on the activity of tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).

Baumann M, Hussain MM, Henne N, Garrote DM, Karlshøj S, Fossen T, Rosenkilde MM, Våbenø J, Haug BE. Baumann M, et al. Among authors: vabeno j. Bioorg Med Chem. 2017 Jan 15;25(2):646-657. doi: 10.1016/j.bmc.2016.11.036. Epub 2016 Nov 21. Bioorg Med Chem. 2017. PMID: 27939345

10

Inhibition of HIV Fusion by Small Molecule Agonists through Efficacy-Engineering of CXCR4.

Berg C, Daugvilaite V, Steen A, Jørgensen AS, Våbenø J, Rosenkilde MM. Berg C, et al. Among authors: vabeno j. ACS Chem Biol. 2018 Apr 20;13(4):881-886. doi: 10.1021/acschembio.8b00061. Epub 2018 Feb 27. ACS Chem Biol. 2018. PMID: 29461034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters